Wuhan General Gr Chn
Wuhan General Group (China), Inc., a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Reno, Nevada.
Wuhan General Gr Chn (WUHN) - Total Liabilities
Latest total liabilities as of September 2022: $7.17 Million USD
Based on the latest financial reports, Wuhan General Gr Chn (WUHN) has total liabilities worth $7.17 Million USD as of September 2022.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Wuhan General Gr Chn - Total Liabilities Trend (2006–2021)
This chart illustrates how Wuhan General Gr Chn's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Wuhan General Gr Chn Competitors by Total Liabilities
The table below lists competitors of Wuhan General Gr Chn ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Checkit PLC
LSE:CKT
|
UK | GBX8.70 Million |
|
International Steels Ltd
KAR:ISL
|
Pakistan | PKRs21.49 Billion |
|
Novonix Limited
BE:GC3
|
Germany | €79.41 Million |
|
Develop North PLC
LSE:DVNO
|
UK | GBX3.15 Million |
|
DOLPHIN CAP INVEST
BE:D5S
|
Germany | €62.72 Million |
Liability Composition Analysis (2006–2021)
This chart breaks down Wuhan General Gr Chn's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 37.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Wuhan General Gr Chn's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Wuhan General Gr Chn (2006–2021)
The table below shows the annual total liabilities of Wuhan General Gr Chn from 2006 to 2021.
| Year | Total Liabilities | Change |
|---|---|---|
| 2021-12-31 | $186.37K | +107.79% |
| 2020-12-31 | $89.69K | -86.39% |
| 2019-12-31 | $659.14K | -99.63% |
| 2012-12-31 | $179.25 Million | +15.65% |
| 2011-12-31 | $155.00 Million | +19.06% |
| 2010-12-31 | $130.18 Million | +82.96% |
| 2009-12-31 | $71.15 Million | +15.73% |
| 2008-12-31 | $61.48 Million | +36.63% |
| 2007-12-31 | $45.00 Million | +42.97% |
| 2006-12-31 | $31.47 Million | -- |